SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-16-114208
Filing Date
2016-04-26
Accepted
2016-04-26 16:05:13
Documents
5
Effectiveness Date
2016-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A a16-9314_3defa14a.htm DEFA14A 32547
2 GRAPHIC g93143bgi001.gif GRAPHIC 49422
3 GRAPHIC g93143bgi002.gif GRAPHIC 100544
4 GRAPHIC g93143bgi003.gif GRAPHIC 22241
5 GRAPHIC g93143bgi004.gif GRAPHIC 4228
  Complete submission text file 0001104659-16-114208.txt   276918
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 161592049
SIC: 2834 Pharmaceutical Preparations